Aldeyra Therapeutics, Inc. (ALDX) insider have most recently took part in a trading activity. On Sep 19, 2017 Perceptive Life Sciences Master Fund Ltd, 10% Owner bought 200,000 shares having total worth of $1,450,000 at the price of $7.25 per share, following the transaction a total of 3,085,458 shares owned by Perceptive Life Sciences Master Fund Ltd. Before this latest buy, Perceptive Life Sciences Master Fund Ltd purchased ALDX at 1 other times during the past twelve months, for a total investment of $13.62M at an average of $4.6 per share.
The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 7 times by insiders. an employee of the company was the buyer in 7 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Aldeyra Therapeutics, Inc. (ALDX) traded down 20.33% on Sep 19, 2017, hitting $7.25. 6,087,759 shares of the company’s stock traded hands. Aldeyra Therapeutics, Inc. has a 52 week low of $3.9 and a 52 week high of $10.8. The company’s market cap is $97 million.
Aldeyra Therapeutics, Inc. (ALDX) last announced its earnings results on Aug 8, 2017. The company reported -0.35 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.39 by $0.04. During the same quarter in the previous year, the company posted -0.41 earnings per share.
|earnings per share||-0.35||-0.37||-0.37||-0.38||-0.41||-0.51||-0.46||-0.35||-0.27||-0.32|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018